This opportunity is no longer accepting applications.
grant PAR-22-032

Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)

This grant supports research for discovering new compounds to prevent and treat nervous system disorders. It focuses on: 1) Identifying, designing, synthesizing, and preclinical testing of therapeutic compounds, 2) Improving compound activity through initial chemistry, 3) Optimizing lead compounds for better efficacy and pharmacokinetics, and 4) Conducting initial drug metabolism and pharmacok…

Reissue of PAR-19-146 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders.
Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testi…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Mental Health
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Opportunity Released: November 29, 2021
Open for Submission: November 17, 2021
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.